Coronavirus [COVID-19] – WHO Public Health Emergency of International Concern (PHEIC)

Milestones :: Perspectives :: Research

Coronavirus [COVID-19] – WHO

Public Health Emergency of International Concern (PHEIC)


Weekly Epidemiological and Operational updates

Last update: 10 Sep 2021

Confirmed cases ::                         230 418 451     [226 844 344 week ago]

Confirmed deaths ::                          4 724 876               [4 666 334 week ago]

Vaccine doses administered:    5 874 934 542   [5 634 533 040 week ago]





WHO Director-General’s remarks at the Member State Information Session on COVID-19


23 September 2021


…Yesterday I had the honour of speaking at the Global COVID-19 Summit hosted by the United States of America, on the margins of the United Nations General Assembly.


I welcome the support from so many Member States for the Secretariat’s global targets to vaccinate 40% of the population of every country by the end of this year, and 70% by the middle of next year.

And I thank President Biden, not only for hosting, but also for the pledges of 500 million doses, which is significant.


As you know, earlier this year we also set a target to see 10% of the population of every country vaccinated by the end of September. Almost 90% of wealthier countries have now reached the 10% target. But 50 countries will not get there, mostly in Africa.


At yesterday’s summit, Secretary-General Antonio Guterres repeated his call for a global vaccination plan. I’m pleased to say that the WHO Secretariat has developed that plan. Today, Dr Bruce Aylward and Dr Kate O’Brien will present the WHO Strategy for achieving our 70% goal by mid-2022.


Reaching this target requires 11 billion doses of vaccines. So far, 6 billion doses have been administered worldwide. Global production has been scaling up, and we estimate there is enough supply, but we are failing to provide equitable access.


But about 80 percent of the vaccines have gone to high and upper-middle income countries. Low income countries have received less than 1%. Let’s be clear: COVID-19 cannot be beaten one country at a time.


My friends, the investment needed to achieve global vaccination coverage is substantial, but compared to the costs we face if this is not brought under control, it is peanuts. Let’s get this finished…




Weekly epidemiological update on COVID-19 – 21 September 2021


   The numbers of weekly COVID-19 cases and deaths globally continued to decline this week, with over 3.6 million cases and just under 60 000 deaths reported between 13-19 September. This brings the cumulative numbers of confirmed cases and deaths globally to nearly 228 million and over 4.6 million respectively. While the Region of the Americas as well as the Eastern Mediterranean, South-East Asia and Western Pacific regions reported a decrease in weekly case incidence, the African and European regions reported a similar number of deaths as compared to the previous week. Similarly, COVID-19 weekly mortality decreased in the African, Eastern Mediterranean and South-East Asian regions over the past week, with the South-East Asia Region reporting the largest percentage decrease (27%). In contrast, the Western Pacific Region reported an increase (7%) in the number of deaths while the Region of the Americas and the European Region reported a similar number of deaths as compared to the previous week.

   In this edition, we provide updates on the impacts of the phenotypic characteristics (transmissibility, disease severity, risk of reinfection, and impacts on diagnostics and vaccine performance) of SARS-CoV-2 Variants of Concern (VOCs), the geographic distribution of VOCs as well as changes to VOI classifications.




Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process  19 August 2021

For 22 vaccine candidates, presents Manufacturer, Name of Vaccine, NRA of Record, Platform, EOI Accepted Status, Pre-submission Meeting Held Status, Dossier Accepted for Review, Status of Assessment; Anticipated/Completed Decision Date
[No updates since 19 Aug 2021]